VR Logo

Burning Rock Biotech Limited (BNR) download report


Healthcare | Diagnostics Services

Burning Rock Biotech Limited (BNR) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China.

IPO Date: 12-Jun-2020

COO & Director: Dr. Shaokun Chuai

Founder, Chairman & CEO: Mr. Yusheng Han

Listing: NASDAQ: BNR

Country: China

Headquarters: Guangzhou,

Website: https://www.brbiotech.com

Key Facts

Market cap: $227.21 Mln

Revenue (TTM): CN¥536.76 Mln

Earnings (TTM): CN¥-925.07 Mln

Cash: CN¥1,329.27 Mln

Total Debt: CN¥77.48 Mln

Insider's Holding: 5.83%

Liquidity: Low

52 Week range: $1.74 - 30.50

Shares outstanding: 105,188,000

5 Years Aggregate:

  • CFO: CN¥-1,061.95 Mln
  • EBITDA: CN¥-1,550.15 Mln
  • Net Profit: CN¥-1,681.86 Mln

Stock Performance

Time Period Burning Rock Biotech (BNR) S&P BSE Sensex S&P Small-Cap 600
YTD-75.34-9.49-17.79
1 month-21.67-2.87-2.72
3 months-75.50-8.59-12.17
1 Year-91.740.81-15.82
3 Years--10.397.14
5 Years--11.116.20
10 Years--12.0010.33
As on 24-Jun-2022
Year Burning Rock Biotech (BNR) S&P Small-Cap 600 S&P BSE Sensex
2021-58.7425.2721.99